Exelixis Competitors and Similar CompaniesClear all
Exelixis's competitors and similar companies include Genocea Biosciences.
 Genocea Biosciences Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. | ||
Founding Date | Founding Date 1994 | Founding Date 2006 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Alameda, US HQ | Locations Cambridge, US HQ |
Employees | Employees 1,14712% decrease | Employees 593% decrease |
Valuation ($) | Valuation ($) 8.2 b | Valuation ($) 5.7 k |
Financial | ||
Revenue (est.) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $1.6m (FY, 2021) |
Net income | Net income $782.6m (FY, 2025) | Net income ($33.2m) (FY, 2021) |
For sources of this data, please see the company profile
View Company Profiles
Genocea Biosciences
HQ
Cambridge, US
Employees
59↓ 3% decrease
Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.
View company